Table of Contents Author Guidelines Submit a Manuscript
Advances in Preventive Medicine
Volume 2011, Article ID 846756, 17 pages
http://dx.doi.org/10.4061/2011/846756
Review Article

Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience

1GlaxoSmithKline Biologicals, 2301 Renaissance Boulevard, King of Prussia, PA 19406, USA
2GlaxoSmithKline Biologicals, Avenue Fleming 20 (W23), 1300 Wavre, Belgium

Received 30 November 2010; Accepted 19 April 2011

Academic Editor: Jodie McVernon

Copyright © 2011 Jacqueline M. Miller et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [22 citations]

The following is the list of published articles that have cited the current article.

  • Juan Carlos Tejedor, José Manuel Merino, Manuel Moro, Maria-Luisa Navarro, José Espín, Félix Omeñaca, José García-Sicilia, David Moreno-Pérez, Jesús Ruiz-Contreras, Fernando Centeno, Francisco Barrio, Lucia Cabanillas, Marta Muro, Carlos Esporrin, Maria Jose De Torres, Magalie Caubet, Dominique Boutriau, Jacqueline M. Miller, and Narcisa Mesaros, “Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine,” The Pediatric Infectious Disease Journal, pp. 1, 2012. View at Publisher · View at Google Scholar
  • Ray Borrow, “Advances with vaccination against Neisseria meningitidis,” Tropical Medicine & International Health, vol. 17, no. 12, pp. 1478–1491, 2012. View at Publisher · View at Google Scholar
  • F. Berti, M.R. Romano, F. Micoli, V. Pinto, E. Cappelletti, M. Gavini, D. Proietti, G. Pluschke, C.A. MacLennan, and P. Costantino, “Relative stability of meningococcal serogroup A and X polysaccharides,” Vaccine, vol. 30, no. 45, pp. 6409–6415, 2012. View at Publisher · View at Google Scholar
  • Jamie D. Croxtall, and Sohita Dhillon, “Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix (TM)),” Drugs, vol. 72, no. 18, pp. 2407–2430, 2012. View at Publisher · View at Google Scholar
  • Soha Ghanem, Sara Hassan, Randa Saad, and Ghassan S. Dbaibo, “Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): a review,” Expert Opinion on Biological Therapy, vol. 13, no. 8, pp. 1197–1205, 2013. View at Publisher · View at Google Scholar
  • Caroline M. Perry, “Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT; MenHibrix (R)): A Review,” Drugs, vol. 73, no. 7, pp. 703–713, 2013. View at Publisher · View at Google Scholar
  • Timo Vesikari, Aino Forsten, Maria Guiseppina Desole, Giuseppe Ferrera, Magalie Caubet, Narcisa Mesaros, and Dominique Boutriau, “A Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C Tetanus Toxoid Conjugate Vaccine Is Immunogenic and Well-tolerated When Coadministered With Diphtheria, Tetanus, Acellular Pertussis Hepatitis B-inactivated Poliovirus at 3, 5 and 11 Months of Age: Results of an Open, Randomized, Controlled Study,” Pediatric Infectious Disease Journal, vol. 32, no. 5, pp. 521–529, 2013. View at Publisher · View at Google Scholar
  • David Pace, “Glycoconjugate vaccines,” Expert Opinion on Biological Therapy, vol. 13, no. 1, pp. 11–33, 2013. View at Publisher · View at Google Scholar
  • Vasilisa Filippenko, Junzhi Wang, Sabrina Gibeault, Matthew C. Cook, Jeremy P. Kunkel, and Qiang Ye, “Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China,” Biologicals, vol. 41, no. 4, pp. 261–268, 2013. View at Publisher · View at Google Scholar
  • Jeremy P. Kunkel, Matthew C. Cook, and Alex Bliu, “Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: Optimisation of hydrolysis conditions and chromatographic methods,” Vaccine, vol. 31, no. 36, pp. 3702–3711, 2013. View at Publisher · View at Google Scholar
  • Jamie Findlow, Helen Findlow, Sarah Frankland, Ann Holland, Daniel Holme, Emma Newton, Jo Southern, Pauline Waight, Ed Kaczmarski, Elizabeth Miller, and Ray Borrow, “Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine,” Journal of Occupational Medicine and Toxicology, vol. 9, 2014. View at Publisher · View at Google Scholar
  • David R. Bundle, Pui-Hang Tam, Ha Huu-Anh Tran, Eugenia Paszkiewicz, Jonathan Cartmell, Joanna M. Sadowska, Susmita Sarkar, Maju Joe, and Pavel I. Kitov, “Oligosaccharides and Peptide Displayed on an Amphiphilic Polymer Enable Solid Phase Assay of Hapten Specific Antibodies,” Bioconjugate Chemistry, vol. 25, no. 4, pp. 685–697, 2014. View at Publisher · View at Google Scholar
  • Yorgo C Zahlanie, Moza M Hammadi, Soha T Ghanem, and Ghassan S Dbaibo, “Review of meningococcal vaccines with updates on immunization in adults,” Human vaccines & immunotherapeutics, vol. 10, no. 4, 2014. View at Publisher · View at Google Scholar
  • Reinaldo Acevedo, Sonsire Fernandez, Caridad Zayas, Armando Acosta, Maria Elena Sarmiento, Valerie A. Ferro, Einar Rosenqyise, Concepcion Campal, Daniel Cardoso, Luis Garcia, and Jose Luis Perez, “Bacterial outer membrane vesicles and vaccine applications,” Frontiers In Immunology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Absatou Ky Ba, Idrissa Sanou, Paul A Kristiansen, Lassana Sangaré, Rasmata Ouédraogo, Kalifa Ouattara, Maxime Kienou, Simon Tiendrebeogo, and Juliette Tranchot, “Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso.,” BMC infectious diseases, vol. 14, pp. 546, 2014. View at Publisher · View at Google Scholar
  • Robert Booy, Terry Nolan, Graham Reynolds, Peter Richmond, Michael Nissen, Helen Marshall, Tanya Stoney, Marie Van Der Wielen, Devayani Kolhe, and Jacqueline M. Miller, “Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C–Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed Toddlers,” The Pediatric Infectious Disease Journal, vol. 34, no. 12, pp. 1379–1384, 2015. View at Publisher · View at Google Scholar
  • Juan Carlos Tejedor, Jerzy Brzostek, Ryszard Konior, Detlef Grunert, Devayani Kolhe, Yaela Baine, and Marie Van Der Wielen, “Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines.,” Clinical and vaccine immunology : CVI, vol. 23, no. 7, pp. 555–63, 2016. View at Publisher · View at Google Scholar
  • Aia Assaf-Casals, and Ghassan Dbaibo, “Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT, Nimenrix™): A review of its Immunogenicity, Safety, Co-Administration, and Antibody Persistence,” Human Vaccines & Immunotherapeutics, pp. 00–00, 2016. View at Publisher · View at Google Scholar
  • Natalia Savelyeva, Alex Allen, Warayut Chotprakaikiat, Elena Harden, Jantipa Jobsri, Rosemary Godeseth, Yidao Wang, Freda Stevenson, and Christian Ottensmeier, “Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination,” 2016. View at Publisher · View at Google Scholar
  • Ali Saber Abdelhameed, Gordon A Morris, Fahad Almutairi, Gary G Adams, Pierre Duvivier, Karel Conrath, and Stephen E Harding, “Solution conformation and flexibility of capsular polysaccharides from Neisseria meningitidis and glycoconjugates with the tetanus toxoid protein.,” Scientific reports, vol. 6, pp. 35588, 2016. View at Publisher · View at Google Scholar
  • Reinaldo Acevedo, Caridad Zayas, Gunnstein Norheim, Sonsire Fernández, Barbara Cedré, Yisabel Aranguren, Maribel Cuello, Yaimara Rodriguez, Humberto González, Aleida Mandiarote, Marylin Pérez, Maritza Hernández, Mabel Hernández-Cedeño, Domingo González, Sverre-Henning Brorson, Einar Rosenqvist, Lisbeth Naess, Gro Tunheim, Daniel Cardoso, and Luis García, “Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa,” Pharmacological Research, 2017. View at Publisher · View at Google Scholar
  • Pumtiwitt C. McCarthy, Abeer Sharyan, and Laleh Sheikhi Moghaddam, “Meningococcal Vaccines: Current Status and Emerging Strategies,” Vaccines, vol. 6, no. 1, pp. 12, 2018. View at Publisher · View at Google Scholar